{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:42:38Z","timestamp":1774525358284,"version":"3.50.1"},"reference-count":27,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,4,21]],"date-time":"2002-04-21T00:00:00Z","timestamp":1019347200000},"content-version":"vor","delay-in-days":475,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2001,1]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> Data from the appearance of RBC antibodies other than ABO in patients undergoing HPC transplantation are limited.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> The incidence and specificity of non\u2010ABO RBC alloantibodies are described in a series of 217 patients undergoing allogeneic HPC transplantation because of various hematologic malignancies.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> Eight patients (3.7%) developed 10 antibodies after transplant. None of these patients had previously been immunized. Seven patients had one RBC antibody and one patient had three RBC antibodies. Antibody specificity were anti\u2010Jk<jats:sup>b<\/jats:sup> (2 patients), \u2010Kell (2), \u2010M (2), \u2010Le<jats:sup>b<\/jats:sup> (1), and \u2010D (1). Finally, two patients had a panagglutinin. The mean time between transplant and antibody detection was 23 days (range, 16\u2010672). The source of the HPCs, the conditioning regimen administered, and the type of GVHD prophylaxis administered did not influence the rate of antibody formation. On multivariate analysis, ABO blood group incompatibility (p = 0.005) and patient\u2032s age (p = 0.02) were the only two variables significantly associated with the development of RBC alloantibodies.<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold> Patients undergoing allogeneic HPC transplantation are at risk of developing RBC\u2010specific antibodies despite the immunosuppressive therapy administered. Antibody formation was more frequently observed in ABO\u2010mismatched cases, which suggests a potential role of this incompatibility in facilitating antibody production.<\/jats:p>","DOI":"10.1046\/j.1537-2995.2001.41010106.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T22:44:46Z","timestamp":1047509086000},"page":"106-110","source":"Crossref","is-referenced-by-count":38,"title":["Development of non\u2010ABO RBC alloantibodies in patients undergoing allogeneic HPC transplantation. Is ABO incompatibility a predisposing factor?"],"prefix":"10.1111","volume":"41","author":[{"given":"Javier","family":"De La Rubia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Arriaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Andreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelly","family":"Carpio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda L.","family":"Marty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,4,21]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.268.5.607"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199403243301206"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)92009-9"},{"key":"e_1_2_5_5_2","first-page":"159","article-title":"Immunohematologic complications of bone marrow transplantation.","volume":"8","author":"Klumpp TR","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199203000-00002"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1987.27287150186.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1995.351196110898.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1984.tb02875.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1992.tb02504.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1998.38398222868.x"},{"key":"e_1_2_5_12_2","volume-title":"Technical manual","author":"Walker RH","year":"1990"},{"key":"e_1_2_5_13_2","first-page":"635","article-title":"A new elution procedure using a nonflammable organic solvent (abstract).","volume":"20","author":"Branch DR","year":"1980","journal-title":"Transfusion"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1976.tb02821.x"},{"key":"e_1_2_5_15_2","volume-title":"BMDP statistical software","author":"Dixon WJ","year":"1990"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1998.38398222864.x"},{"key":"e_1_2_5_17_2","first-page":"46","article-title":"Hemolysis in Rh\u2010negative female recipient after Rh\u2010incompatible bone marrow transplantation for chronic myeloid leukemia.","volume":"71","author":"Girelli G","year":"1986","journal-title":"Haematologica"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1983.23483276858.x"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1988.28388219159.x"},{"key":"e_1_2_5_20_2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1182\/blood.V67.1.177.177","article-title":"Donor\u2010derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation.","volume":"67","author":"Hows J","year":"1986","journal-title":"Blood"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198912213212507"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198803000-00005"},{"key":"e_1_2_5_23_2","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1182\/blood.V79.11.3076.bloodjournal79113076","article-title":"Hemolysis of transfused group O red blood cells in minor ABO\u2010incompatible unrelated\u2010donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate.","volume":"79","author":"Gajewski JL","year":"1992","journal-title":"Blood"},{"issue":"4","key":"e_1_2_5_24_2","first-page":"3","article-title":"The influence of total dose, fractionation, dose rate, and distribution of total body irradiation on bone marrow transplantation.","volume":"20","author":"Appelbaum FR","year":"1993","journal-title":"Semin Oncol"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1999.39070763.x"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199505270-00013"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199106000-00010"},{"key":"e_1_2_5_28_2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1182\/blood.V67.3.770.770","article-title":"Bone marrow transplantation in patients aged 45 years and older.","volume":"67","author":"Klingemann HG","year":"1986","journal-title":"Blood"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1537-2995.2001.41010106.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1537-2995.2001.41010106.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T22:12:05Z","timestamp":1697494325000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1537-2995.2001.41010106.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["10.1046\/j.1537-2995.2001.41010106.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1537-2995.2001.41010106.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}